Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Daiichi Sankyo Signs Hep B Vaccine Agreement

By R&D Editors | August 28, 2014

Daiichi Sankyo Co. Ltd. announced that it has signed a cooperative sales agreement with The Chemo-Sero-Therapeutic Research Institute (Kaketsuken) on Aug. 22 for its recombinant adsorbed hepatitis B vaccine (yeast-derived), Bimmugen.
 
Kaketsuken originally obtained approval for the vaccine in 1988 as a genetic recombinant drug manufactured using proprietary Japanese technology. The main aim of the vaccine is prophylaxis against hepatitis B, and to date the vaccine has been administered to over 4 million people in Japan.
 
This agreement grants Daiichi Sankyo the right to sell the vaccine in Japan, which it hopes will aid prevention of hepatitis B, as well as further raise the company’s presence in the Japanese vaccine market.
 
Through the sale of vaccines to meet unmet medical needs, Daiichi Sankyo is continuing its efforts to contribute to public health and the diversification of preventative medicine in Japan.
 
Date: August 28, 2014
Source: Daiichi Sankyo

Related Articles Read More >

IBM’s second-generation, 156-qubit Quantum Heron processors offer reduced error rates, 16× better performance, and 25× faster speeds than 2022 systems. The Heron can run quantum circuits with up to 5,000 two-qubit gate operations using Qiskit—nearly double what IBM achieved in 2023.
Quantum computing edges closer to biotech reality in Moderna-IBM pact
New nanopore sensor paves the way for fast, accurate, low-cost DNA sequencing
E. coli makes Tylenol from plastic waste
2025 R&D layoffs tracker hits 132,075 as Amazon CEO signals AI will cut more jobs
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE